Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder AsiaPacific Fund Regulatory News (SDP)

Share Price Information for Schroder AsiaPacific Fund (SDP)

Share Price is delayed by 15 minutes
Get Live Data
852.00    -2.00 (-0.23%)
Bid:
852.00
Ask:
855.00
Spread: 3.00 (0.352%)
Market Cap: £1.07b
SDP Live PriceLast checked at - London Stock Exchange

Intraday Schroder AsiaPacific Fund Share Chart

Directorate change

17 Apr 2026 07:00

RNS Number : 8266A
Schroder AsiaPacific Fund PLC
17 April 2026
 

17 April 2026

Schroder AsiaPacific Fund plc

Directorate Change

 

Schroder AsiaPacific Fund plc (the "Company") is pleased to announce the appointment of John Lydon as an independent non-executive Director of the Company, with effect from 1 May 2026. He will also be a member of the Audit and Risk, Nomination and Management Engagement Committees.

Mr Lydon has over 30 years' experience in M&A, capital markets, strategic advisory and investment across Europe, Asia, and North America. He has held various leadership roles in the financial sector at J.P. Morgan, Deutsche Bank and Davy Group, and in the industrial sector at CRH plc. Mr Lydon is currently a Venture Partner at Princeville Capital, a leading global growth-stage technology investor.

 

Nicky Richards, Chair of the Board, commented:

 

"The Board is pleased to welcome John Lydon as an independent non-executive Director. His deep international experience in M&A, capital markets and strategic advisory will add strength to the Board and its Committees. We look forward to working with him."

 

 

It is confirmed that there are no other details to be disclosed concerning Mr Lydon under UK Listing Rule 6.4.8R.

 

Enquiries:

 

Natalia de Sousa

Schroder Investment Management Limited

Tel: 0207 658 6000

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUWUCUPQGQQ
Date   Source Headline
28th Jan 202510:30 amRNSNet Asset Value(s)
27th Jan 20254:42 pmRNSTransaction in Own Shares
27th Jan 202510:27 amRNSNet Asset Value(s)
27th Jan 20257:00 amRNSAppointment of Non-Executive Director
24th Jan 20254:41 pmRNSTransaction in Own Shares
24th Jan 202510:32 amRNSNet Asset Value(s)
23rd Jan 202511:41 amRNSNet Asset Value(s)
22nd Jan 20254:47 pmRNSTransaction in Own Shares
22nd Jan 202511:41 amRNSNet Asset Value(s)
21st Jan 20254:30 pmRNSTransaction in Own Shares
21st Jan 202510:07 amRNSNet Asset Value(s)
20th Jan 20254:39 pmRNSTransaction in Own Shares
20th Jan 202510:22 amRNSNet Asset Value(s)
17th Jan 20255:10 pmRNSTransaction in Own Shares
17th Jan 202510:10 amRNSNet Asset Value(s)
16th Jan 202510:34 amRNSNet Asset Value(s)
15th Jan 20254:46 pmRNSTransaction in Own Shares
15th Jan 202510:42 amRNSNet Asset Value(s)
14th Jan 20254:45 pmRNSHolding(s) in Company
14th Jan 202511:05 amRNSNet Asset Value(s)
13th Jan 20254:52 pmRNSTransaction in Own Shares
13th Jan 202510:38 amRNSNet Asset Value(s)
10th Jan 20254:54 pmRNSTransaction in Own Shares
10th Jan 202512:28 pmRNS-RVirtual Presentation
10th Jan 202510:20 amRNSNet Asset Value(s)
9th Jan 20255:00 pmRNSTransaction in Own Shares
9th Jan 202511:11 amRNSNet Asset Value(s)
8th Jan 20254:48 pmRNSTransaction in Own Shares
8th Jan 202510:43 amRNSNet Asset Value(s)
7th Jan 20254:56 pmRNSTransaction in Own Shares
7th Jan 202511:29 amRNSNet Asset Value(s)
6th Jan 20255:05 pmRNSTransaction in Own Shares
6th Jan 202511:01 amRNSNet Asset Value(s)
3rd Jan 202510:36 amRNSNet Asset Value(s)
2nd Jan 20254:09 pmRNSTransaction in Own Shares
2nd Jan 202512:44 pmRNSPortfolio Update
2nd Jan 202511:26 amRNSNet Asset Value(s)
31st Dec 202412:08 pmRNSTotal Voting Rights
31st Dec 202410:43 amRNSNet Asset Value(s)
30th Dec 202410:23 amRNSNet Asset Value(s)
27th Dec 202412:28 pmRNSTransaction in Own Shares
27th Dec 202410:18 amRNSNet Asset Value(s)
24th Dec 202410:40 amRNSNet Asset Value(s)
23rd Dec 202410:16 amRNSNet Asset Value(s)
20th Dec 20244:30 pmRNSTransaction in Own Shares
20th Dec 202410:28 amRNSNet Asset Value(s)
19th Dec 202411:14 amRNSNet Asset Value(s)
18th Dec 20244:49 pmRNSTransaction in Own Shares
18th Dec 202410:30 amRNSNet Asset Value(s)
17th Dec 20245:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.